All News #Library
Others
Invenra Welcomes Three Industry Leaders to Its Board of Directors
17 Sep 2024 //
BUSINESSWIRE
Invenra`s INV724 Gets Rare Pediatric And Orphan Drug Designations For NB
23 Aug 2024 //
BUSINESSWIRE
Invenra Highlights Exelixis` Phase 1 Trial Of XB010 In Advanced Solid Tumors
07 Aug 2024 //
BUSINESSWIRE
Invenra to Present Preclinical Data on INV322
20 Sep 2022 //
BUSINESSWIRE
Exelixis and Invenra expand partnership to develop cancer antibodies
17 Aug 2021 //
PHARMACEUTICALTECHNOLOGY
Exelixis and Invenra Expand Collaboration to Develop Novel Biologics in Oncology
16 Aug 2021 //
BUSINESSWIRE

Market Place
Sourcing Support